The Valley Desk

NCT05520567 · Interventional trial

A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov